Document is current
Any future updates will be listed below
-
Authors
Lee, Keun Wook
Zang, Da Young
Kim, Hyung-Don
Kim, Jin-Won
Kim, Bum Jun
Kang, Yoon-Koo
Ryu, Min-Hee https://orcid.org/0000-0002-1033-1263
Kim, Hark Kyun
- License Information
-
More Information
Article History
Received: 3 November 2024
Revised: 24 April 2025
Accepted: 1 May 2025
First Online: 21 May 2025
Competing interests
: Nothing directly related to this work. Outside of this work, LKW reported receiving research funding for clinical trials from MSD, AstraZeneca, Ono Pharmaceutical, Roche, Merck KGaA, BeiGene, Astellas Pharma, Amgen, Daiichi Sankyo, ALX Oncology, Leap Therapeutics, GlaxoSmithKline, Macrogenics, Taiho Pharmaceutical, Seagen, Y-BIOLOGICS, Bolt Biotherapeutics, Trishula Therapeutics, InventisBio, MedPacto, Ildong Pharmaceutical, Genome & Company, Arcus Biosciences, Elevar Therapeutics, Jazz Pharmaceuticals, TRIO Oncology, Exelixis, IgM Biosciences, Panolos Bioscience, Metafines, Wellmarker Bio, Medicenna, and Erasca. He also received consulting fees from Daiichi Sankyo, MSD, Astellas Pharma, AbbVie, and Metafines; honoraria for lectures or presentations from Sanofi/Aventis, Astellas Pharma, Bayer, Daiichi Sankyo, and Merck KGaA; and has an uncompensated role with ALX Oncology on a data safety monitoring or advisory board. YKK has a consulting or advisory role with ALX Oncology, Amgen, Blueprint Medicines, Bristol-Myers Squibb, DAEHWA Pharmaceutical, Macrogenics, Novartis, Surface Oncology, and Zymeworks. MHR received honoraria from DAEHWA Pharmaceuticals, Bristol Myers Squibb, Lilly, Ono Pharmaceuticals, MSD, Taiho Pharmaceuticals, Novartis, Daiichi Sankyo, and AstraZeneca; and served as a consultant for DAEHWA Pharmaceuticals, Bristol Myers Squibb, Lilly, and Ono Pharmaceuticals. HDK received research grants from Roche/Genentech and AstraZeneca and honoraria from AstraZeneca, Bristol Myers Squibb, Ono Pharmaceuticals, Boryung Pharmaceuticals, MSD, Daiichi Sankyo, Astellas, Boostimmune, and MustBio.
: This study was approved by the Institutional Review Board of each participating center. All patients provided written informed consent. This study was performed in accordance with the ethical standards of the Institutional Research Committee and the latest Declaration of Helsinki.
